Morgan Stanley to price autocallable jump securities linked to Sage

New York, March 27 – Morgan Stanley Finance LLC plans to price 0% jump securities with autocallable feature due April 1, 2021 linked to the common stock of Sage Therapeutics, Inc., according to a 424B2 with the Securities and Exchange Commission.

If the stock closes at or above the threshold value, 85% of the initial price, on a quarterly determination date other than the final one then the notes will be automatically called at par plus a call premium of 13.35% per year.

If the notes are not called prior to maturity and the stock finishes at or above the threshold value, the payout at maturity will be par plus 40.05%.

Otherwise, investors will be fully exposed to the share price decline.

Morgan Stanley is the agent.

The notes will be guaranteed by Morgan Stanley.

Pricing is scheduled for March 29 and settlement will follow on April 4.

The Cusip number is 61768P595.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.